- Home
- / Absci
Absci
Stock Price
$4.2
2024-10-29
Market Capitalization
$487.2 M
2024-10-29
Revenue
$2.8 M
FY, 2025
Absci Summary
Company Summary
- Overview
- AbSci is a company that provides generative AI drug-creation solutions. It offers an AI drug discovery platform to design antibodies to wet lab-validated candidates.
- Type
- Public
- Status
- Active
- Founded
- 2011
- HQ
- Vancouver, WA, US | view all locations
- Website
- https://www.absci.com
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
4 locations detected
Vancouver, WA HQ
United States
18105 SE Mill Plain Blvd
New York, NY
United States
152 West 57th St, 21st Floor
Belgrade
Serbia
Cara Uroša 18
Zug, ZG
Switzerland
Baarerstrasse 14
Absci Financials
Summary Financials
- Revenue (Q1, 2026)
- $215.0K
- Net income (Q1, 2026)
- ($29.6M)
- Cash (Q1, 2026)
- $8.6M
- EBIT (Q1, 2026)
- ($30.8M)
- Enterprise value
- $482.9M